The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions.


Journal

Canadian respiratory journal
ISSN: 1916-7245
Titre abrégé: Can Respir J
Pays: Egypt
ID NLM: 9433332

Informations de publication

Date de publication:
2020
Historique:
received: 15 03 2020
revised: 24 07 2020
accepted: 22 09 2020
entrez: 21 10 2020
pubmed: 22 10 2020
medline: 8 9 2021
Statut: epublish

Résumé

Thoracic ultrasound is an essential tool in the daily clinical care of pleural effusions and especially parapneumonic pleural effusions (PPEs), in terms of diagnosis, management, and follow-up. Hypoechogenicity index (HI) is a quantitative marker of pleural fluid echogenicity. We aimed to examine associations of HI with pleural inflammation in patients with PPE. All patients included underwent a thoracic ultrasound with HI determination at the first day of their admission for a PPE. Thoracentesis was performed in all patients. Demographics, laboratory measurements, and clinical data were collected prospectively and recorded in all subjects. Twenty-four patients with PPE were included in the study. HI was statistically significantly correlated with intensity of inflammation as suggested by pleural fluid LDH (

Sections du résumé

Background
Thoracic ultrasound is an essential tool in the daily clinical care of pleural effusions and especially parapneumonic pleural effusions (PPEs), in terms of diagnosis, management, and follow-up. Hypoechogenicity index (HI) is a quantitative marker of pleural fluid echogenicity. We aimed to examine associations of HI with pleural inflammation in patients with PPE.
Methods
All patients included underwent a thoracic ultrasound with HI determination at the first day of their admission for a PPE. Thoracentesis was performed in all patients. Demographics, laboratory measurements, and clinical data were collected prospectively and recorded in all subjects.
Results
Twenty-four patients with PPE were included in the study. HI was statistically significantly correlated with intensity of inflammation as suggested by pleural fluid LDH (

Identifiants

pubmed: 33082889
doi: 10.1155/2020/1283590
pmc: PMC7556052
doi:

Substances chimiques

L-Lactate Dehydrogenase EC 1.1.1.27
Glucose IY9XDZ35W2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1283590

Informations de copyright

Copyright © 2020 Charalampos Varsamas et al.

Déclaration de conflit d'intérêts

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Références

Semin Respir Infect. 1999 Mar;14(1):3-8
pubmed: 10197392
J Thorac Dis. 2017 Mar;9(3):543-546
pubmed: 28449461
J Bras Pneumol. 2014 Jan-Feb;40(1):6-12
pubmed: 24626264
Chest. 2004 Oct;126(4):1274-80
pubmed: 15486393
Ultrasound Med Biol. 2009 Sep;35(9):1468-74
pubmed: 19616366
Expert Rev Respir Med. 2017 Apr;11(4):323-331
pubmed: 28345480
Chest. 1976 Sep;70(03):328-31
pubmed: 8283
Curr Opin Infect Dis. 2013 Apr;26(2):196-202
pubmed: 23286936
Lung. 2017 Feb;195(1):135-138
pubmed: 27866276
Thorax. 2017 Jan;72(1):94-95
pubmed: 27613540
Clin Chest Med. 1998 Jun;19(2):373-82
pubmed: 9646988
Arch Intern Med. 1978 Sep;138(9):1378-80
pubmed: 28707
Eur Radiol. 2000;10(3):495-9
pubmed: 10757003
Clin Respir J. 2018 Aug;12(8):2309-2320
pubmed: 30005142
Chest. 2004 Dec;126(6):2022-4
pubmed: 15596709
Am Rev Respir Dis. 1991 Jul;144(1):187-94
pubmed: 2064128
AJR Am J Roentgenol. 1992 Jul;159(1):29-33
pubmed: 1609716
AJR Am J Roentgenol. 1991 Jun;156(6):1145-53
pubmed: 2028857
N Engl J Med. 2011 Aug 11;365(6):518-26
pubmed: 21830966
Semin Respir Crit Care Med. 2014 Dec;35(6):715-22
pubmed: 25463162
Respiration. 2012;83(4):323-9
pubmed: 22301442
Respirology. 2018 Feb;23(2):232
pubmed: 29071758
Lancet Respir Med. 2015 Jul;3(7):563-77
pubmed: 26170076
Eur Respir J. 2007 Nov;30(5):957-64
pubmed: 17690119
Thorax. 2010 Aug;65 Suppl 2:ii4-17
pubmed: 20696692
Clin Radiol. 2000 Jul;55(7):542-7
pubmed: 10924379

Auteurs

Charalampos Varsamas (C)

Respiratory Medicine Department, University of Thessaly, School of Medicine, Larissa, Greece.

Alexandros Kalkanis (A)

Louvain University Center for Sleep and Wake Disorders, Leuven, Belgium.

Konstantinos I Gourgoulianis (KI)

Respiratory Medicine Department, University of Thessaly, School of Medicine, Larissa, Greece.

Foteini Malli (F)

Respiratory Medicine Department, University of Thessaly, School of Medicine, Larissa, Greece.
Respiratory Disorders Lab, Nursing Department, University of Thessaly, Larissa, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH